سعر ايتوريكوكس -هيكسال 90 مجم 30 قرص 2024

Etoricoxib 90 mg film-coated tablets, pack of 30 (Etoricox-Hexal; Hexal AG, Germany).

• Symptomatic relief of osteoarthritis (OA), rheumatoid arthritis (RA), ankylosing spondylitis, and pain and signs of inflammation associated with acute gouty arthritis.Population: Adults and adolescents 16 years and olderelectronic medicines compendium (eMC), United Kingdom
• Short-term treatment of moderate pain associated with dental surgery.Population: Adults and adolescents 16 years and olderelectronic medicines compendium (eMC), United Kingdom

• Very common: abdominal pain. Common: alveolar osteitis, oedema/fluid retention, dizziness, headache, palpitations, arrhythmia, hypertension, bronchospasm, constipation, flatulence, gastritis, heartburn/acid reflux, diarrhoea, dyspepsia, nausea, vomiting, oesophagitis, mouth ulcer, ALT/AST increased, ecchymosis, asthenia/fatigue, flu-like disease.International label, equivalent formulation · electronic medicines compendium (eMC), United Kingdom

• Hypersensitivity to etoricoxib or any excipient.International label, equivalent formulation · electronic medicines compendium (eMC), United Kingdom
• Active peptic ulceration or active gastro-intestinal bleeding; inflammatory bowel disease.International label, equivalent formulation · electronic medicines compendium (eMC), United Kingdom
• History of bronchospasm, acute rhinitis, nasal polyps, angioneurotic oedema, urticaria or allergic-type reactions after aspirin or NSAIDs, including COX-2 inhibitors.International label, equivalent formulation · electronic medicines compendium (eMC), United Kingdom

• Upper gastrointestinal complications (perforations, ulcers or bleedings), some fatal, have occurred; risk is higher in the elderly, with concomitant NSAIDs or aspirin, or a prior history of GI disease.International label, equivalent formulation · electronic medicines compendium (eMC), United Kingdom
• Selective COX-2 inhibitors may increase the risk of thrombotic events (especially myocardial infarction and stroke); risk may increase with dose and duration, so use the lowest effective daily dose for the shortest duration.International label, equivalent formulation · electronic medicines compendium (eMC), United Kingdom
• Fluid retention, oedema and hypertension may occur; control blood pressure before treatment and monitor it within two weeks of starting and periodically thereafter. Renal function should be monitored in patients with pre-existing renal impairment, heart failure or cirrhosis.International label, equivalent formulation · electronic medicines compendium (eMC), United Kingdom

• Warfarin (oral anticoagulants)Etoricoxib 120 mg daily increased the prothrombin time INR by about 13%; monitor INR closely when starting or changing etoricoxib therapy.electronic medicines compendium (eMC), United Kingdom
• Diuretics, ACE inhibitors and angiotensin II antagonistsModerateNSAIDs may reduce the effect of diuretics and antihypertensives; in patients with compromised renal function the combination may further deteriorate renal function, including possible acute renal failure.electronic medicines compendium (eMC), United Kingdom
• LithiumNSAIDs decrease renal lithium excretion and increase lithium plasma levels; monitor lithium levels.electronic medicines compendium (eMC), United Kingdom

• Contraindicated in pregnancy; no clinical data in pregnancy, animal studies showed reproductive toxicity. Discontinue if a woman becomes pregnant during treatment.International label, equivalent formulation · electronic medicines compendium (eMC), United Kingdom
• Excreted in the milk of lactating rats; women who use etoricoxib must not breastfeed.International label, equivalent formulation · electronic medicines compendium (eMC), United Kingdom

• Etoricoxib: Selective COX-2 inhibitor within the clinical dose range; no inhibition of COX-1 at doses up to 150 mg daily (UK Arcoxia SmPC).